Functional nanoplatforms overcoming immune resistance in skin cancers: Targeted immunomodulation, immunogenic cell death, and metabolic remodeling
Cancer Letters · 2026-06 · 647 · 218439
DOI: 10.1016/j.canlet.2026.218439 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Letters, 2026-06. Verfasst von Chunyan Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasonic Diagnosis, The First Hospital of China Medical University, No. 155 Nanjing Bei Street, Shenyang, Liaoning, 110001, China. Hauptthemen laut MEDLINE: Skin Neoplasms, Immunogenic Cell Death. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 231 Literaturangaben. Gefördert von: Beijing Medical and Health Foundation, Liaoning Provincial Natural Science Foundation.
Abstract (Originalsprache)
Skin cancers, including melanoma, cutaneous squamous cell carcinoma (cSCC), and Merkel cell carcinoma (MCC), present a fundamental paradox: high tumor immunogenicity coexists with profound immune evasion, driven by oncogenic signaling, an immunosuppressive microenvironment, metabolic dysregulation, and fibrotic stroma. Multifunctional nanoplatforms offer a systems-level strategy to overcome this multilayered resistance. They enable coordinated reprogramming of immune checkpoints and myeloid compartments, precise induction of immunogenic cell death through organelle-targeted stress or novel death pathways like cuproptosis, and synergistic use of photo-, ultrasound-, or magnetic-energy triggers. Concurrently, these platforms remodel the tumor microenvironment by scavenging immunosuppressive metabolites, exploiting lineage-specific metabolic vulnerabilities, and degrading fibrotic barriers to restore T-cell infiltration. The integration of computational intelligence-spanning AI-driven nanocarrier design, multi-omics-based patient stratification, and real-time biomarker monitoring-further empowers adaptive therapeutic strategies. By unifying biomimetic delivery, stimuli-responsive activation, and energy-coupled immunomodulation, advanced nanocarriers actively reconfigure tumor-immune crosstalk, demonstrating synergistic antitumor efficacy in preclinical models of melanoma, cSCC, and MCC. Successful clinical translation, however, requires addressing key challenges: scalable manufacturing of complex constructs, proactive management of cytokine-driven immunotoxicity, and robust biomarker-guided patient selection. The future of nano-immunotherapy lies in adaptive platforms that leverage liquid biopsy and computational modeling to dynamically counter the spatiotemporal evolution of resistance, offering a transformative paradigm for managing aggressive skin cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ultrasonic Diagnosis, The First Hospital of China Medical University, No. 155 Nanjing Bei Street, Shenyang, Liaoning, 110001, China.
- Department of Intervention, The Fourth Affiliated Hospital of China Medical University, No. 4 Chongshan East Road, Shenyang, 110032, China.
- Second Ward of Bone and Soft Tissue Tumor Surgery, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning Province, 1100…
- Department of Ultrasonic Diagnosis, The First Hospital of China Medical University, No. 155 Nanjing Bei Street, Shenyang, Liaoning, 110001, China. Electronic address: liyinyan0510@163.com.
Förderung
- Beijing Medical and Health Foundation
- Liaoning Provincial Natural Science Foundation
Zitieren
APA
Wang, C., Sun, J., Song, J., Li, S., & Li, Y. (2026). Functional nanoplatforms overcoming immune resistance in skin cancers: Targeted immunomodulation, immunogenic cell death, and metabolic remodeling. Cancer Letters, 647, 218439. https://doi.org/10.1016/j.canlet.2026.218439
Vancouver
Wang C, Sun J, Song J, Li S, Li Y. Functional nanoplatforms overcoming immune resistance in skin cancers: Targeted immunomodulation, immunogenic cell death, and metabolic remodeling. Cancer Letters. 2026;647:218439. doi:10.1016/j.canlet.2026.218439
BibTeX
@article{Wang2026,
author = {Wang, Chunyan and Sun, Jun and Song, Jianbo and Li, Shenglong and Li, Yinyan},
title = {Functional nanoplatforms overcoming immune resistance in skin cancers: Targeted immunomodulation, immunogenic cell death, and metabolic remodeling},
journal = {Cancer Letters},
year = {2026},
volume = {647},
pages = {218439},
doi = {10.1016/j.canlet.2026.218439}
}
EUVIMED